Your browser doesn't support javascript.
loading
Reducing the harms of xylazine: clinical approaches, research deficits, and public health context.
Zagorski, Claire M; Hosey, Rebecca A; Moraff, Christopher; Ferguson, Aaron; Figgatt, Mary; Aronowitz, Shoshana; Stahl, Natalie E; Hill, Lucas G; McElligott, Zoe; Dasgupta, Nabarun.
Afiliação
  • Zagorski CM; College of Pharmacy, The University of Texas at Austin, 2409 University Avenue, A1910, PHR 3.208J, Austin, TX, 78712, USA. claire.zagorski@austin.utexas.edu.
  • Hosey RA; HIV Prevention Research Division, Department of Psychiatry, School of Medicine, University of Pennsylvania, 3535 Market Street, Suite 4000, Philadelphia, PA, 19104, USA.
  • Moraff C; Narcomedia, Inc., Philadelphia, PA, USA.
  • Ferguson A; National Survivors Union, 1116 Grove St, Greensboro, NC, 27403, USA.
  • Figgatt M; Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, 135 Dauer Drive, Chapel Hill, NC, 27599, USA.
  • Aronowitz S; University of Pennsylvania School of Nursing, Fagin Hall, 418 Curie Blvd, Philadelphia, PA, 19104, USA.
  • Stahl NE; Greater Lawrence Family Health Center, 34 Haverhill Street, Lawrence, MA, 01841, USA.
  • Hill LG; College of Pharmacy, The University of Texas at Austin, 2409 University Avenue, A1910, PHR 3.208J, Austin, TX, 78712, USA.
  • McElligott Z; Department of Pharmacology, Bowles Center for Alcohol Studies, University of North Carolina, CB#7178, 104 Manning Road, Chapel Hill, NC, 2759, USA.
  • Dasgupta N; University of North Carolina, 725 MLK Jr. Blvd., CB 7505, Chapel Hill, NC, 27599, USA.
Harm Reduct J ; 20(1): 141, 2023 09 30.
Article em En | MEDLINE | ID: mdl-37777769

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Xilazina / Saúde Pública Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Xilazina / Saúde Pública Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article